-+ 0.00%
-+ 0.00%
-+ 0.00%

*Viking Therapeutics Phase 3 Trials for Subcutaneous VK2735 Expected to Begin 2Q >VKTX

Dow Jones·04/23/2025 21:18:00

Please log in to view news